September 2022 in “XXXIX Congresso Brasileiro de Reumatologia” Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.
Researchers created a new mouse model, G4, that mimics human PCOS symptoms and links the condition to a specific gene.
125 citations
,
September 2019 in “Journal of Clinical Immunology” Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.
June 2020 in “The journal of investigative dermatology/Journal of investigative dermatology” The enzymes Tet1, Tet2, and Tet3 are important for the development of hair follicles and determining hair shape by controlling hair keratin genes.
October 2006 in “Urology” The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.
SMAD4 is crucial for muscle repair in young adults but not in aged mice.
15 citations
,
September 2018 in “Applied Biological Chemistry” Matrigel supports cell growth and repair, and thymosin beta 4 aids tissue regeneration and healing.
1 citations
,
October 2021 in “The journal of investigative dermatology/Journal of investigative dermatology” Removing HIF-P4H-2 from certain skin cells in mice causes hair loss on the body but not the head.
119 citations
,
September 2000 in “Journal of Biological Chemistry” GKLF/KLF4 and Sp1 control Keratin 19 gene activity, influencing cancer-related changes.
November 2021 in “bioRxiv (Cold Spring Harbor Laboratory)” 4-aminopyridine helps skin wounds heal faster and better.
September 2025 in “International Journal of Dermatology”
22 citations
,
April 1998 in “Dermatologic Clinics” Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.
October 2021 in “International Journal of Cosmetic Science” 2 citations
,
August 2020 in “CRC Press eBooks” Tabby mutations in mice affect hair follicle development and help study genetic mapping and certain medical conditions.
39 citations
,
June 2019 in “Frontiers in Endocrinology” Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.
November 2023 in “Veterinary Dermatology” 1 citations
,
February 2023 in “Journal of Cosmetic Dermatology” 1 citations
,
July 2021 in “Dermatologic Therapy” 1 citations
,
November 2019 in “Dermatologic Therapy” December 2025 in “Lasers in Surgery and Medicine” February 2025 in “International Journal of Dermatology” February 2025 in “Australasian Journal of Dermatology” October 2022 in “Journal of Cosmetic Dermatology” May 2021 in “FEBS open bio” January 2021 in “Dermatologic Therapy” November 2020 in “Dermatologic Therapy” August 2020 in “International Journal of Dermatology” May 2020 in “Dermatologic Therapy” March 2020 in “Dermatologic Therapy” February 2020 in “Stem Cells Translational Medicine”